Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

2 terminated/withdrawn out of 14 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

21%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

Phase 1/2

2(25.0%)

Phase 2

2(25.0%)

Phase 3

2(25.0%)

Phase 4

1(12.5%)

N/A

1(12.5%)

8Total

Phase 1/2(2)

Phase 2(2)

Phase 3(2)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT07841080Phase 3Not Yet Recruiting

Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study

Role: collaborator

NCT04031872Phase 1/2Withdrawn

LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Role: collaborator

NCT03482362Phase 2Completed

Vinorelbine in Advanced BRAF-like Colon Cancer

Role: collaborator

NCT06884631Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Role: collaborator

NCT03359538Phase 2Completed

Rapamycin Treatment for ALS

Role: collaborator

NCT06530472Unknown

The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic

Role: collaborator

NCT05769686Completed

Laparoscopic Donor Nephrectomy Score, a New Scoring System for Preoperative Prediction of Difficulty of Laparoscopic Donor Nephrectomy

Role: collaborator

NCT04434417Completed

Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

Role: collaborator

NCT03470350Phase 1/2Withdrawn

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer

Role: collaborator

NCT03858088Completed

Early Allograft Failure Simplified Estimation (EASE) in Liver Transplantation

Role: collaborator

NCT03498664Not ApplicableUnknown

EMR-C VS EMR-S in Colonic Lateral Spreading Tumors Treatment (LST)

Role: collaborator

NCT01411579Completed

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

Role: collaborator

NCT01360346Phase 3Unknown

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Role: collaborator

NCT01158846Phase 4Unknown

Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

Role: collaborator

All 14 trials loaded